SEC Form 4 · accession 0000856982-18-000038
MERIT MEDICAL SYSTEMS INC · MMSI
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Justin J. Lampropoulos
Officer — EVP GLOBAL SALES, MKTG & STGY
Period of report
Jun 5, 2018
Accepted (ET)
Jun 7, 2018 · 4:40 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000856982
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, No Par Value | Jun 5, 2018 | M | 14,000 | $13.75 | A | 14,000 | D | |
| Common Stock, No Par ValueF1 | Jun 5, 2018 | S | 14,000 | $51.309 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Non-qualified stock options (right to buy)F2 | $13.75 | Jun 5, 2018 | M | 14,000 | D | Aug 11, 2012 | Aug 11, 2018 | Common Stock | 14,000 | 0 | D |
| Non-qualified stock options (right to buy)F3 | $13.14 | holding | — | — | — | Jul 31, 2014 | Jul 31, 2020 | Common Stock | 8,000 | 8,000 | D |
| Non-qualified stock options (right to buy)F4 | $12.06 | holding | — | — | — | Oct 4, 2015 | Oct 4, 2021 | Common Stock | 25,000 | 25,000 | D |
| Non-qualified stock options (right to buy)F5 | $17.27 | holding | — | — | — | Feb 13, 2016 | Feb 13, 2022 | Common Stock | 20,000 | 20,000 | D |
| Non-qualified stock options (right to buy)F6 | $16.05 | holding | — | — | — | Jan 28, 2017 | Jan 28, 2023 | Common Stock | 20,000 | 20,000 | D |
| Non-qualified stock options (right to buy)F7 | $28.20 | holding | — | — | — | Apr 14, 2018 | Apr 14, 2024 | Common Stock | 25,000 | 25,000 | D |
| Non-qualified stock options (right to buy)F8 | $44.80 | holding | — | — | — | Mar 2, 2019 | Mar 2, 2025 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The price reported in Column 4 of Table 1 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $51.20 to $51.45, inclusive. The Reporting Person undertakes to provide to Merit Medical Systems, Inc., any security holder of Merit Medical Systems, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
- F2Becomes exercisable in equal annual installments of 20% commencing on 08/11/2012.
- F3Becomes exercisable in equal annual installments of 20% commencing on 07/31/2014.
- F4Becomes exercisable in equal annual installments of 20% commencing on 10/04/2015.
- F5Becomes exercisable in equal annual installments of 20% commencing on 02/13/2016.
- F6Becomes exercisable in equal annual installments of 20% commencing on 01/28/2017.
- F7Becomes exercisable in equal annual installments of 20% commencing on 04/14/2018.
- F8Becomes exercisable in equal annual installments of 20% commencing on 03/02/2019.